Literature DB >> 30908631

Epithelial-mesenchymal transition induced cancer-stem-cell-like characteristics in hepatocellular carcinoma.

Li Jing1, Zhiping Ruan1, Haifeng Sun2, Qing Li1, Lili Han3, Lanxuan Huang1, Sizhe Yu1, Yu Wang1, Hui Guo1, Min Jiao1.   

Abstract

Hepatocellular carcinoma in China accounts for half of the world's incidence. Both epithelial-mesenchymal transition (EMT) and cancer stem cells (CSCs) are thought to be involved in tumor malignant progression. However, the relationship between EMT and CSCs is still unclear. Bioinformatics analysis was performed to evaluate the relationship between EMT and CSCs. The EMT and CSC regulatory mechanism was investigated through Transwell, wound-healing, sphere formation, colony-forming, and western blotting assays. Immunofluorescence and immunoprecipitation were used to study the interaction of hypoxia inducible factor 1α (HIF-1α) /Notch1. Immunohistochemical study was applied to investigate the expression pattern in the process of hepatocellular carcinogenesis and development. In our present study, bioinformatics results indicate that the expression of EMT-related molecules is correlated with CSCs. In vitro studies indicated that EMT activation could induce CSC characteristics. Notch1 was confirmed to mediate the process of EMT-induced CSCs through the interaction with HIF-1α directly. Our findings indicate that EMT could induce CSC-like characteristics, which is mediated by HIF-1α-upregulated Notch intracellular domain expression.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  CSCs; EMT; HCC; HIF-1α; Notch1

Mesh:

Substances:

Year:  2019        PMID: 30908631     DOI: 10.1002/jcp.28480

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

Review 1.  Clinical and Biological Implications of Cancer Stem Cells in Hepatocellular Carcinoma.

Authors:  Hiroyuki Tsuchiya; Goshi Shiota
Journal:  Yonago Acta Med       Date:  2021-01-06       Impact factor: 1.641

Review 2.  Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance.

Authors:  Masoud Najafi; Bagher Farhood; Keywan Mortezaee; Ebrahim Kharazinejad; Jamal Majidpoor; Reza Ahadi
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-16       Impact factor: 4.553

3.  Inhibition of Bone Morphogenetic Protein 2 Suppresses the Stemness Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma via the MAPK/ERK Pathway.

Authors:  Juncheng Guo; Min Guo; Jinfang Zheng
Journal:  Cancer Manag Res       Date:  2021-01-27       Impact factor: 3.989

Review 4.  Hypoxia‑inducible factors in hepatocellular carcinoma (Review).

Authors:  Yang Guo; Zunqiang Xiao; Liu Yang; Yuling Gao; Qiaojuan Zhu; Linjun Hu; Dongsheng Huang; Qiuran Xu
Journal:  Oncol Rep       Date:  2019-11-01       Impact factor: 3.906

5.  The F-box protein FBXO11 restrains hepatocellular carcinoma stemness via promotion of ubiquitin-mediated degradation of Snail.

Authors:  Lijiang Shao; Xuehui Zhang; Qi Yao
Journal:  FEBS Open Bio       Date:  2020-07-26       Impact factor: 2.693

Review 6.  Current research progress in the role of reactive oxygen species in esophageal adenocarcinoma.

Authors:  Youzhen Hu; Xiaojun Ye; Ruihua Wang; Karen Poon
Journal:  Transl Cancer Res       Date:  2021-03       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.